Serum β-glucuronidase as a potential colon cancer marker: a preliminary study

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2015, Vol 69, Issue 0

Abstract

Colorectal cancer is characterized by high morbidity and mortality in developed countries. The lack of low-cost, easy-to-use screening diagnostic methods is one of the causes of late diagnosis of colorectal cancer. Beta-glucuronidase (GLU) is a lysosomal exoglycosidase involved in degradation of glycosaminoglycans of the cell membranes and extracellular matrix of normal and cancerous colon tissues. The aim of our research was to evaluate the activity of GLU in the serum of colorectal cancer and estimate its potential value in the diagnosis of colorectal cancer.Blood samples were collected from 21 patients with colorectal adenocarcinoma and 17 healthy subjects. GLU activity was determined by the colorimetric method of Marciniak et al. by measuring the amount of p-nitrophenol released from 4-nitrophenyl-beta-D-glucuronide, at λ = 405 nm.We found significantly greater activity of GLU (p<0.0001) in the serum of patients with colorectal cancer, as compared to the healthy subjects. The serum GLU activity significantly differentiates patients with colorectal cancer from healthy individuals.Serum GLU activity has diagnostic value and may be used in the diagnosis of colon adenocarcinoma.

Authors and Affiliations

Napoleon Waszkiewicz, Sławomir Dariusz Szajda, Emilia Konarzewska-Duchnowska, Beata Zalewska-Szajda, Robert Gałązkowski, Anna Sawko, Halim Nammous, Vyacheslav Buko, Agata Szulc, Krzysztof Zwierz, Jerzy Robert Ładny

Keywords

Related Articles

Pathophysiology and molecular basis of selected metabolic abnormalities in Huntington’s disease

Huntington’s disease (HD) is an incurable, devastating neurodegenerative disease with a known genetic background and autosomally dominant inheritance pattern. HTT gene mutation (mHTT) is associated with polymorphic fragm...

The use of physiotherapy in the regeneration of periapical bone structures of the teeth, prepared to load the prosthetic

The aim of this work was to investigate whether the use of magnetoledotherapy will accelerate the elimination of osteolytic lesions of the dental periapical area, and provide for prosthetic treatment. What impact on time...

Przegląd zaburzeń β -oksydacji kwasów tłuszczowych

Kwasy tłuszczowe (FA) są składnikiem błon komórkowych, enzymów, hormonów oraz jednym z najważniejszych źródeł energii dla wielu organizmów. W komórce odbywa się wiele procesów oksydacyjnej degradacji kwasów tłuszczowych:...

The importance of pharmacogenetic tests in evaluation of the effectiveness of methotrexate treatment in rheumatoid arthritis (part 1)

Methotrexate (MTX) is still the gold standard in the treatment of rheumatoid arthritis and is used worldwide in more than 0.5 million patients with RA. Much hope is currently associated with the individualization of th...

Download PDF file
  • EP ID EP67654
  • DOI -
  • Views 144
  • Downloads 0

How To Cite

Napoleon Waszkiewicz, Sławomir Dariusz Szajda, Emilia Konarzewska-Duchnowska, Beata Zalewska-Szajda, Robert Gałązkowski, Anna Sawko, Halim Nammous, Vyacheslav Buko, Agata Szulc, Krzysztof Zwierz, Jerzy Robert Ładny (2015). Serum β-glucuronidase as a potential colon cancer marker: a preliminary study. Advances in Hygiene and Experimental Medicine, 69(0), 436-439. https://europub.co.uk/articles/-A-67654